BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

768 related articles for article (PubMed ID: 33089794)

  • 21. Hypersensitivity reactions to proton-pump inhibitors: Clinical presentation, diagnosis, and management.
    Kepil Özdemir S; Bavbek S
    Allergy Asthma Proc; 2020 Mar; 41(2):e37-e44. PubMed ID: 32122452
    [No Abstract]   [Full Text] [Related]  

  • 22. Late hypersensitivity to omeprazole and other proton pump inhibitors.
    Pirson F; Geubel A; Marot L
    Acta Clin Belg; 2012; 67(4):301-3. PubMed ID: 23019809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypersensitivity reactions to proton pump inhibitors. An EAACI position paper.
    Bavbek S; Kepil Özdemir S; Bonadonna P; Atanaskovic-Markovic M; Barbaud A; Brockow K; Laguna Martinez J; Nakonechna A; Pagani M; Arcolacı A; Lombardo C; Torres MJ
    Allergy; 2024 Mar; 79(3):552-564. PubMed ID: 38013608
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dermatologic adverse reactions to proton-pump inhibitors: A synthetized review.
    Salloum A; Nasr D; Maalouf D
    J Cosmet Dermatol; 2021 Apr; 20(4):1073-1079. PubMed ID: 33031621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypersensitivity reactions to proton pump inhibitors in childhood.
    Mori F; Franceschini F; Saretta F; Bianchi A; Bottau P; Caimmi S; Crisafulli G; Liotti L; Paglialunga C; Caffarelli C
    Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26():29-32. PubMed ID: 33236429
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A case report of fixed drug eruption caused by several drugs because of cross-reactivity and co-sensitization.
    Sobrino-García M; Gómez-Cardeñosa A; Moreno-Rodilla E; Muñoz-Bellido FJ; Lázaro-Sastre M; Dávila I
    Contact Dermatitis; 2019 Jan; 80(1):56-57. PubMed ID: 30246872
    [No Abstract]   [Full Text] [Related]  

  • 27. Immediate and Delayed Hypersensitivity Reactions to Proton Pump Inhibitors: Evaluation and Management.
    Otani IM; Banerji A
    Curr Allergy Asthma Rep; 2016 Mar; 16(3):17. PubMed ID: 26810177
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prevalence of gastroesophageal reflux disease symptoms and effects of esomeprazole on the quality of life related to reflux and dyspepsia in patients on maintenance hemodialysis.
    Namikoshi T; Harada K; Hatta H; Tokura T; Oshiro Y; Nishizaki T; Obata T; Mori M; Fueki T; Fujimoto S; Haruna Y; Kuwabara A; Yorimitsu D; Ihoriya C; Kadoya H; Itano S; Fujimoto Y; Komai N; Sasaki T; Kashihara N
    Clin Exp Nephrol; 2016 Feb; 20(1):134-42. PubMed ID: 26026991
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Allergy to lansoprazole: study of cross-reactivity among proton-pump inhibitors.
    Porcel S; Rodríguez A; Jiménez S; Alvarado M; Hernández J
    Allergy; 2005 Aug; 60(8):1087-8. PubMed ID: 15969693
    [No Abstract]   [Full Text] [Related]  

  • 30. Fatal outcome of DRESS syndrome associated with esomeprazole.
    Zaïem A; Charfi O; Badri T; Elaidli S
    Indian J Dermatol Venereol Leprol; 2015; 81(4):407-8. PubMed ID: 26087082
    [No Abstract]   [Full Text] [Related]  

  • 31. [Lupus erythematosus and proto-pump inhibitors].
    Schmutz JL; Trechot P
    Ann Dermatol Venereol; 2014 Mar; 141(3):252-3. PubMed ID: 24635967
    [No Abstract]   [Full Text] [Related]  

  • 32. Delayed-type hypersensitivity rash from paracetamol.
    Irion R; Gall H; Werfel T; Peter RU
    Contact Dermatitis; 2000 Jul; 43(1):60-1. PubMed ID: 10902603
    [No Abstract]   [Full Text] [Related]  

  • 33. Esomeprazole fixed drug eruption.
    Salloum A; Nasr D; Maalouf D
    Contact Dermatitis; 2020 May; 82(5):334-335. PubMed ID: 31967328
    [No Abstract]   [Full Text] [Related]  

  • 34. Nonallergic anaphylaxis to pantoprazole.
    Kaatz M; Bauer A; Hipler C; Elsner P
    Allergy; 2002 Feb; 57(2):184. PubMed ID: 11929432
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anaphylaxis due to proton pump inhibitors: current understanding and important clinical considerations.
    Benito-Garcia F; Chambel M; Morais-Almeida M
    Expert Rev Clin Immunol; 2018 Aug; 14(8):653-656. PubMed ID: 30058396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Proton pump inhibitor-induced hypomagnesemic hypoparathyroidism.
    Swaminathan K
    Indian J Pharmacol; 2015; 47(3):330-1. PubMed ID: 26069375
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ranitidine-induced anaphylaxis: clinical features, cross-reactivity, and skin testing.
    Park KH; Pai J; Song DG; Sim DW; Park HJ; Lee JH; Jeong KY; Pan CH; Shin I; Park JW
    Clin Exp Allergy; 2016 Apr; 46(4):631-9. PubMed ID: 26764898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ménétrier Mimicker Complicating Ulcerative Colitis: Proton-Pump Inhibitor-Induced Hyperplastic Polyps.
    Parks T; Ragland KL; Steiner MA; Subramony C; Bishop P; Nowicki M
    J Pediatr; 2015 Sep; 167(3):776.e1. PubMed ID: 26209527
    [No Abstract]   [Full Text] [Related]  

  • 39. Randomised trial of the effect of a gastrin/CCK
    Boyce M; van den Berg F; Mitchell T; Darwin K; Warrington S
    Eur J Clin Pharmacol; 2017 Feb; 73(2):129-139. PubMed ID: 27796466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Esomeprazole-induced ashy dermatosis-like drug eruptions.
    Chang HC; Chang YS; Wang KH; Cheng T; Tsai HH
    Australas J Dermatol; 2019 Aug; 60(3):e232-e233. PubMed ID: 30565221
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.